The Asia Pacific Spine Bone Stimulators Market would witness market growth of 4.7% CAGR during the forecast period (2022-2028).
Surgically inserting titanium, titanium-alloy, stainless steel, or non-metallic substances into the spine is known as spinal instrumentation. The spine is a long-term solution for spinal instability. Medical implants are available in a wide range of shapes, sizes, and designs, all of which are intended to cure spinal problems in persons of different ages. Spondylolisthesis, degenerative disc degeneration, and other spinal anomalies are treated with spine bone stimulators devices. The market is expanding due to an increase in the older population and the frequency of spinal illnesses.
Fractures, trauma, deformity, tumors, and degenerative diseases can all cause the spinal system to become unstable. Aside from these reasons, a blocked blood supply, traumas, infections, and compression caused by a tumor or shattered bone can all result in spinal cord injury. Spine bone stimulators devices give stability when the spinal system loses strength due to the disorders listed above. In recent years, the market for spine bone stimulators devices has profited from a rise in the occurrence of spinal cord injuries.
Asia Pacific has a considerable market for spine bone stimulator devices due to an increase in the prevalence of spinal disorders and higher healthcare spending. Furthermore, the rapidly aging population, as well as the cheaper cost of spinal procedures in developing countries such as India compared to affluent countries, has increased the demand for spinal implants. Significant institutions in India do spinal surgery, including numerous multi-faculty spinal surgery facilities and super-specialty hospitals that perform complex and sophisticated surgeries like microscopic spine surgery. The desire for spine bone stimulators is predicted to rise as a result of the aforementioned difficulties.
The demand for spinal arthrodesis devices is likely to increase throughout the forecast period, owing to favorable reimbursement for spine operations and the increased frequency of degenerative diseases and spine fractures in the Asia Pacific. In September 2019, the Australian government announced changes to the Medicare Benefits Schedule (MBS) items for spine procedures, ensuring that patients who have spinal surgery are properly reimbursed. This is expected to help the Asia Pacific market grow even further.
The China market dominated the Asia Pacific Spine Bone Stimulators Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $49.5 million by 2028. The Japan market is experiencing a CAGR of 4.1% during (2022 - 2028). Additionally, The India market would exhibit a CAGR of 5.3% during (2022 - 2028).
Based on Device Type, the market is segmented into Non-Invasive and Invasive. Based on End User, the market is segmented into Hospitals, Specialty Clinics, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Spine Bone Stimulators Market is Projected to reach USD 626.2 Million by 2028, at a CAGR of 4.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include DJO Global, Inc. (Enovis), Zimmer Biomet, Orthofix Medical Inc., Elizur Corporation, Ossatec Benelux BV, IGEA S.p.A., ManaMed Inc., Theragen, Inc., Intelligent Implants, and Orchid Medical, Inc
By Device Type
By End User
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 